Company intelligence / Profile preview
Hepion Pharmaceuticals
Edison, New Jersey, United Stateshepionpharma.com ↗
- Ownership
- Public · HEPA
- Employees
- ~25
- Development stage
- Phase 2
01
Overview
Hepion's lead drug candidate rencofilstat was in Phase 2b clinical trials for NASH, but the company announced in April 2024 that it has begun wind-down activities for its ASCEND-NASH trial due to resource constraints. The trial had enrolled 151 subjects against a target of 336, with approximately 80 subjects completing their Day 365 visits. The company cited low probability of generating relevant efficacy data to support a registrational trial with current cash resources as the reason for winding down the program.
- Therapeutic areas
- GastroenterologyOncologyRheumatology
- Modalities
- Small molecules (oral small molecule rencofilstat)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Financials
- Market cap
- $663.7K
- Total revenue
- $0
- Enterprise value
- $-964.9K
Beyond the preview
Go deeper on Hepion Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepion Pharmaceuticals.